Cargando…
A microfluidic system that replicates pharmacokinetic (PK) profiles in vitro improves prediction of in vivo efficacy in preclinical models
Test compounds used on in vitro model systems are conventionally delivered to cell culture wells as fixed concentration bolus doses; however, this poorly replicates the pharmacokinetic (PK) concentration changes seen in vivo and reduces the predictive value of the data. Herein, proof-of-concept expe...
Autores principales: | Singh, Dharaminder, Deosarkar, Sudhir P., Cadogan, Elaine, Flemington, Vikki, Bray, Alysha, Zhang, Jingwen, Reiserer, Ronald S., Schaffer, David K., Gerken, Gregory B., Britt, Clayton M., Werner, Erik M., Gibbons, Francis D., Kostrzewski, Tomasz, Chambers, Christopher E., Davies, Emma J., Montoya, Antonio Ramos, Fok, Jacqueline H. L., Hughes, David, Fabre, Kristin, Wagoner, Matthew P., Wikswo, John P., Scott, Clay W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135222/ https://www.ncbi.nlm.nih.gov/pubmed/35617197 http://dx.doi.org/10.1371/journal.pbio.3001624 |
Ejemplares similares
-
Application of a Human Blood Brain Barrier Organ-on-a-Chip Model to Evaluate Small Molecule Effectiveness against Venezuelan Equine Encephalitis Virus
por: Boghdeh, Niloufar A., et al.
Publicado: (2022) -
Benchmarking pK(a )prediction
por: Davies, Matthew N, et al.
Publicado: (2006) -
Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unit
por: Brown, Jacquelyn A., et al.
Publicado: (2016) -
AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity
por: Fok, Jacqueline H. L., et al.
Publicado: (2019) -
Characterization of
prickle
isoform-specific
pk
(pk1)
and
pk
(sple1)
mutations in
Drosophila melanogaster
por: Lilienthal, Anthony J, et al.
Publicado: (2022)